Human Cytomegalovirus Envelope Glycoprotein B Market Report

Global Human Cytomegalovirus Envelope Glycoprotein B Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Jun 22, 2020
  • PAGES：161
  • REPORT CODE：GMM578148
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Human Cytomegalovirus Envelope Glycoprotein B is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of 2.5% during the forecast period. The research provides insights for the global Human Cytomegalovirus Envelope Glycoprotein B market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Human Cytomegalovirus Envelope Glycoprotein B industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Human Cytomegalovirus Envelope Glycoprotein B Market Segmentations:

    By Players:

    • Vical Incorporated

    • VBI Vaccine Inc

    • Vakzine Projekt Management GmbH

    By Types:

    • CSJ-148

    • CyMVectin

    • TRL-345

    • PPCM

    • Cytomegalovirus Vaccine

    • Others

    By End-User:

    • Infectious Disease

    • Oncology

    • Women's Health

    • Others

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Human Cytomegalovirus Envelope Glycoprotein B Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CSJ-148 from 2014 to 2026

      • 1.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CyMVectin from 2014 to 2026

      • 1.3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of TRL-345 from 2014 to 2026

      • 1.3.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of PPCM from 2014 to 2026

      • 1.3.5 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Cytomegalovirus Vaccine from 2014 to 2026

      • 1.3.6 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Infectious Disease from 2014 to 2026

      • 1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Oncology from 2014 to 2026

      • 1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Women's Health from 2014 to 2026

      • 1.4.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Human Cytomegalovirus Envelope Glycoprotein B Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Human Cytomegalovirus Envelope Glycoprotein B by Major Types

      • 3.4.1 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CSJ-148

      • 3.4.2 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CyMVectin

      • 3.4.3 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of TRL-345

      • 3.4.4 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of PPCM

      • 3.4.5 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Cytomegalovirus Vaccine

      • 3.4.6 Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others

    4 Segmentation of Human Cytomegalovirus Envelope Glycoprotein B Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Human Cytomegalovirus Envelope Glycoprotein B by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B in Infectious Disease

      • 4.4.2 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B in Oncology

      • 4.4.3 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B in Women's Health

      • 4.4.4 Market Size and Growth Rate of Human Cytomegalovirus Envelope Glycoprotein B in Others

    5 Market Analysis by Major Regions

    • 5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Production Analysis by Major Regions

    • 5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Analysis by Major Regions

    • 5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    6 Product Commodity of Human Cytomegalovirus Envelope Glycoprotein B Market in Major Countries

    • 6.1 Top 5 Export Countries in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 7.1 North America Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 7.2 North America Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 7.3 North America Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Countries

      • 7.3.1 United States Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 7.3.2 Canada Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 7.3.3 Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    8 Europe Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 8.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 8.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 8.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Countries

      • 8.3.1 Germany Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.2 UK Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.3 France Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.4 Italy Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.6 Spain Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.7 Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.8 Poland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.9 Russia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 8.3.10 Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    9 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 9.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 9.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Countries

      • 9.3.1 China Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 9.3.2 Japan Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 9.3.4 India Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 9.3.6 South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 10.3.2 Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 10.3.3 Nigeria Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

      • 10.3.4 South Africa Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate 

      • 10.3.5 Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 Vical Incorporated

      • 11.1.1 Vical Incorporated Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 VBI Vaccine Inc

      • 11.2.1 VBI Vaccine Inc Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Vakzine Projekt Management GmbH

      • 11.3.1 Vakzine Projekt Management GmbH Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 97 Figures and 191 Tables)

    • Figure Product Picture

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CSJ-148 from 2014 to 2026

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of CyMVectin from 2014 to 2026

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of TRL-345 from 2014 to 2026

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of PPCM from 2014 to 2026

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Cytomegalovirus Vaccine from 2014 to 2026

    • Figure Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Oncology from 2014 to 2026

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Women's Health from 2014 to 2026

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Human Cytomegalovirus Envelope Glycoprotein B Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Human Cytomegalovirus Envelope Glycoprotein B Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Human Cytomegalovirus Envelope Glycoprotein B

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Human Cytomegalovirus Envelope Glycoprotein B by Different Types from 2014 to 2026

    • Table Consumption Share of Human Cytomegalovirus Envelope Glycoprotein B by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of CSJ-148

    • Figure Market Size and Growth Rate of CyMVectin

    • Figure Market Size and Growth Rate of TRL-345

    • Figure Market Size and Growth Rate of PPCM

    • Figure Market Size and Growth Rate of Cytomegalovirus Vaccine

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Human Cytomegalovirus Envelope Glycoprotein B by Different End-Users from 2014 to 2026

    • Table Consumption Share of Human Cytomegalovirus Envelope Glycoprotein B by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Infectious Disease

    • Figure Market Size and Growth Rate of Oncology

    • Figure Market Size and Growth Rate of Women's Health

    • Figure Market Size and Growth Rate of Others

    • Table Global Human Cytomegalovirus Envelope Glycoprotein B Production by Major Regions

    • Table Global Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Regions

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Regions in 2014

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Regions in 2018

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Production Share by Major Regions in 2026

    • Table Global Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Regions

    • Table Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Regions

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Regions in 2014

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Regions in 2018

    • Figure Global Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Regions in 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Human Cytomegalovirus Envelope Glycoprotein B market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2014

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2018

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2014

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2018

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2014

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2018

    • Figure North America Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2026

    • Figure United States Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2014

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2018

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2014

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2018

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2014

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2018

    • Figure Europe Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2026

    • Figure Germany Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure France Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2014

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2018

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2014

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2018

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2026

    • Figure China Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandHuman Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure India Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Consumption Share by Major Countries in 2026

    • Figure GCC Countries Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Human Cytomegalovirus Envelope Glycoprotein B Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Vical Incorporated

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vical Incorporated

    • Figure Sales and Growth Rate Analysis of Vical Incorporated

    • Figure Revenue and Market Share Analysis of Vical Incorporated

    • Table Product and Service Introduction of Vical Incorporated

    • Table Company Profile and Development Status of VBI Vaccine Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of VBI Vaccine Inc

    • Figure Sales and Growth Rate Analysis of VBI Vaccine Inc

    • Figure Revenue and Market Share Analysis of VBI Vaccine Inc

    • Table Product and Service Introduction of VBI Vaccine Inc

    • Table Company Profile and Development Status of Vakzine Projekt Management GmbH

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vakzine Projekt Management GmbH

    • Figure Sales and Growth Rate Analysis of Vakzine Projekt Management GmbH

    • Figure Revenue and Market Share Analysis of Vakzine Projekt Management GmbH

    • Table Product and Service Introduction of Vakzine Projekt Management GmbH


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US